Endocannabinoids can shut down virulence programs in gut bacteria | Research

The takeaway

The endocannabinoid 2-AG directly inhibited bacterial virulence in mice, protecting them from gut infections caused by Enterobacteriaceae pathogens.

Readers interested in gut health, the microbiome, and novel functions of the endocannabinoid system.

2-AG directly inhibited bacterial virulence by blocking the QseC receptor

What the researchers found

Mice with elevated 2-AG levels were protected from enteric infection. The endocannabinoid directly blocked the bacterial receptor QseC, a signaling molecule that activates pathogen attack systems.

Why it matters

This is the first demonstration that endocannabinoids are directly sensed by bacteria and can modulate bacterial behavior, opening a new avenue for understanding how the endocannabinoid system influences gut health and infection resistance.

The numbers in context

The study identified QseC, a histidine kinase encoded in the core Enterobacteriaceae genome, as the receptor through which 2-AG blocks type three secretion systems essential for infection.

How the study worked

Researchers used mouse models with elevated 2-AG levels and exposed them to Enterobacteriaceae pathogens. They identified the bacterial receptor QseC as the target through which 2-AG inhibits virulence gene expression.

What this study cannot tell us

This was an animal study using mouse models, and the relevance to human gut infections remains to be established. The study focused on Enterobacteriaceae pathogens specifically.

How to read the evidence

Preliminary: animal study demonstrating a novel mechanism, not yet validated in humans.

When this study was published

Published in 2020 in Cell.

The bigger picture

The finding suggests endocannabinoids play a previously unknown role in host defense against gut infections, adding antimicrobial properties to the growing list of endocannabinoid system functions.

Questions still open

Could cannabinoid-based therapies help prevent or treat certain bacterial gut infections? Do phytocannabinoids like THC or CBD have similar effects on bacterial virulence?

Common questions

How did endocannabinoids protect against infection?

2-AG blocked the bacterial receptor QseC, which pathogens need to activate their attack systems. Without this signal, bacteria could not mount an effective infection.

Does this mean cannabis prevents gut infections?

Not necessarily. This study used the body's own endocannabinoid (2-AG), not plant-derived cannabinoids. Whether phytocannabinoids produce similar effects on bacteria is unknown.

Read the original research

Endocannabinoids Inhibit the Induction of Virulence in Enteric Pathogens.

Cell, 183(3), 650-665.e15

View on PubMed ↗Publisher’s paper ↗

Citation

Ellermann, Melissa; Pacheco, Alline R; Jimenez, Angel G; Russell, Regan M; Cuesta, Santiago; Kumar, Aman; Zhu, Wenhan; Vale, Gonçalo; Martin, Sarah A; Raj, Prithvi; McDonald, Jeffrey G; Winter, Sebastian E; Sperandio, Vanessa. (2020). Endocannabinoids Inhibit the Induction of Virulence in Enteric Pathogens.. Cell, 183(3), 650-665.e15. https://doi.org/10.1016/j.cell.2020.09.022